EUVIMEDEUVIMED entdecken
Evaluationsstudie

Clinical and Analytical Evaluation of a Commercial Aspergillus fumigatus Real-time PCR Assay for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematological Malignancies

Charles Gibert iD, Jeanne Bigot iD, Eolia Brissot iD, Anne Banet, Nicolas Millet iD, Christophe Hennequin iD, Juliette Guitard iD

The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · 776-786

DOI: 10.1093/infdis/jiag280 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 31.05.2026. Verfasst von Charles Gibert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Hematologic Neoplasms, Aspergillus fumigatus, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive pulmonary aspergillosis (IPA) is a severe complication of hematological malignancies. The European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) includes Aspergillus polymerase chain reaction (PCR) as a mycological criterion for IPA.

Methods

We retrospectively studied patients who underwent at least 2 Aspergillus fumigatus (Af) real-time PCR (qPCR) tests. Patients were classified according to the EORTC/MSGERC definitions, with or without considering qPCR results. We assessed the impact of qPCR on antifungal management and evaluated analytical specificity using non-Af molds DNA.

Results

We analyzed 296 serum and 136 respiratory specimens from 153 adults with hematological malignancies. Overall, using 1 positive qPCR as an IPA diagnostic criterion yielded a sensitivity and specificity of 0.73 and 0.71, respectively, whereas requiring 2 positive qPCR results reduced sensitivity to 0.31 and increased specificity to 0.93. Diagnostic performance differed according to specimen type. In blood specimens, sensitivity ranged from 0.33 with 1 positive qPCR result to 0.13 with 2 positive qPCR results, while specificity increased from 0.73 to 0.95. In respiratory specimens, sensitivity ranged from 0.70 to 0.60, with specificity from 0.60 to 0.87. Four patients with possible infection were reclassified as probable IPA and were treated with antifungals during routine care. Analytical testing revealed cross-reactivity with non-fumigatus Aspergillus species and non-Aspergillus molds.

Conclusions

The performance of Af-qPCR in real-life settings depends on specimen type and positivity criteria. Cross-reactivities with other molds exist. Af-qPCR results should be interpreted cautiously, considering mycological and clinical data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisHematologic NeoplasmsAspergillus fumigatusReal-Time Polymerase Chain ReactionHumansRetrospective StudiesFemaleSensitivity and SpecificityMiddle AgedMaleAdultAged

Stichwörter der Autor:innen

antifungal managementcross-reactionshematological malignanciesinvasive pulmonary aspergillosispolymerase chain reaction

Autor:innen und Institutionen

  • Service de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
  • GRC40 SoLID, Sorbonne Study Group for Lung Infectious Diseases, Sorbonne Université, Paris, France.
  • Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, Paris, France.
  • Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP Service d'Hématologie Clinique et de Thérapie Cellulaire, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Paris, France.
  • Service d'Hématologie Clinique et de Thérapie Cellulaire, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Paris, France.
  • Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.

ORCID-Profile: Charles Gibert, Jeanne Bigot, Eolia Brissot, Nicolas Millet, Christophe Hennequin, Juliette Guitard

Zitieren

APA

Gibert, C., Bigot, J., Brissot, E., Banet, A., Millet, N., Hennequin, C., & Guitard, J. (2026). Clinical and Analytical Evaluation of a Commercial Aspergillus fumigatus Real-time PCR Assay for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematological Malignancies. The Journal of Infectious Diseases, 234(5), 776-786. https://doi.org/10.1093/infdis/jiag280

Vancouver

Gibert C, Bigot J, Brissot E, Banet A, Millet N, Hennequin C, et al. Clinical and Analytical Evaluation of a Commercial Aspergillus fumigatus Real-time PCR Assay for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematological Malignancies. The Journal of Infectious Diseases. 2026;234(5):776-786. doi:10.1093/infdis/jiag280

BibTeX
@article{Gibert2026,
  author = {Gibert, Charles and Bigot, Jeanne and Brissot, Eolia and Banet, Anne and Millet, Nicolas and Hennequin, Christophe and Guitard, Juliette},
  title = {Clinical and Analytical Evaluation of a Commercial Aspergillus fumigatus Real-time PCR Assay for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematological Malignancies},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {5},
  pages = {776--786},
  doi = {10.1093/infdis/jiag280}
}
Kostenlos starten →